From training to travel, Cyclingnews looks at how junior riders are tackling the changes that come with signing a ...

Motorsport fans love to talk lap times, aero packages and tyre strategy, but there’s another performance frontier that rarely ...

Two small spaceports in the far north of Sweden and Norway are racing to launch the first satellites from mainland Europe into space as the region looks to reduce its reliance on U.S. players. Kristy ...

Cops arrested the apparent driver, a then 17-year-old named Carlos D. Martinez, and charged him with multiple felonies, ...

I’ve endured numerous rounds of radiation and taken thousands of pills—but CAR-T is the most effective therapy I’ve completed ...

WIMBLEDON is facing calls to move parts of its iconic queue – to save bats. A short section of the lengthy path to The Championships, where 10,000 people a day have camped or waited to get in, ...

Robert Wickens was a rising IndyCar star when a horrific crash changed his life and career. Now, with assistance from Bosch, ...

Conducted in collaboration with Professor Huji Xu’s clinical team at Shanghai Changzheng Hospital, this work marks the first-ever application of iPSC-CAR-NK cells in treating autoimmune disease, ...

Join us on an adrenaline-fueled journey as Motobilt takes on the challenge of fixing our Jeep's fuel cell. Watch as the experts tackle rust and wear to bring our Jeep's fuel system back to life ...

A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma.

Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced (armore ...

Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and predicts that a treatment could be approved in the next 5-10 years.